Therapeutic apheresis in children: special considerations (Q37978684)

26 August 2017

Therapeutic apheresis in children: special considerations (English)

1 reference

26 August 2017

Stuart L Goldstein

1

1 reference

26 August 2017

25 January 2012

1 reference

26 August 2017

1 reference

26 August 2017

25

1 reference

26 August 2017

2

1 reference

26 August 2017

165-170

1 reference

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

26 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Modified RIFLE criteria in critically ill children with acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Plasmapheresis and renal replacement therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Epidemiology, clinical presentation, and pathophysiology of atypical and recurrent hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Apheresis treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation: re-analysis of published case-reports and case-series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Erythrocytapheresis in children with sickle cell disease and acute chest syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Erythrocytapheresis can reduce iron overload and prevent the need for chelation therapy in chronically transfused pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

The international bone marrow transplant registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Peripheral blood progenitor cell collection in low-weight children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Photopheresis: clinical applications and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Technical considerations for renal replacement therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Use of totally implantable catheters for peripheral blood stem cell apheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

Complications of apheresis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1525-139X.2011.01028.X

10.1111/J.1525-139X.2011.01028.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22277133